Home > Call For Paper > DNA and RNA Vaccines

DNA and RNA Vaccines

DNA and RNA vaccines represent groundbreaking advancements in vaccination technology. Unlike traditional vaccines that use weakened or inactivated viruses, DNA vaccines deliver a small circular DNA strand, and RNA vaccines use messenger RNA to instruct cells to produce harmless viral proteins, thereby triggering an immune response. These vaccines are highly adaptable, enabling rapid development to combat emerging diseases like COVID-19. They offer advantages such as safety, efficiency, and scalability, potentially revolutionizing future vaccine development by streamlining production and distribution processes. Their ability to induce robust immune responses without using live viruses enhances their appeal in managing infectious diseases effectively. DNA and RNA vaccines signify a promising frontier in vaccine technology, promising to play a pivotal role in global health strategies and pandemic preparedness.

  • mRNA Technology
  • Vaccine Delivery Systems
  • Antigen Expression
  • Immunogenicity and Efficacy
  • Safety and Tolerability
  • Manufacturing and Stability
  • Regulatory Approval
  • Applications and Adaptability
 
SUBMIT ABSTRACT
  +1-404-759-9729
Subscribe To Our Newsletter
499740
TOP